MedPath

INSTITUTE OF LIVER AND BILIARY SCIENCES

INSTITUTE OF LIVER AND BILIARY SCIENCES logo
🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

To Study the Immunomodulating Effects and Safety Profile of ω3 and ω6 PUFA Containing Intravenous Lipid Emulsion in Patients With Acute on Chronic Liver Failure

Not Applicable
Completed
Conditions
Chronic Liver Failure
Interventions
Drug: ω3 PUFA (Polyunsaturated fatty acids) (10% Omegavan 100 ml)
Drug: ω6 PUFA (Polyunsaturated fatty acids) (10% Intralipid 100 ml)
First Posted Date
2016-02-25
Last Posted Date
2018-09-05
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
90
Registration Number
NCT02691533
Locations
🇮🇳

Institute of liver and Biliary Sciences, New Delhi, Delhi, India

TEG (Thromboelastography) Based Versus Conventional Coagulation Parameters Based Correction of Coagulopathy in Non Variceal Bleed.

Not Applicable
Completed
Conditions
Non Variceal Bleed
Interventions
Biological: Fresh Frozen Plasma
Biological: Platelets Concentrate
Biological: Cryo Precitipitate
First Posted Date
2016-02-23
Last Posted Date
2018-11-28
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
96
Registration Number
NCT02689232
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

🇮🇳

Institute of liver and Biliary Sciences, New Delhi, Delhi, India

Randomized Controlled Trial Comparing the Efficacy and Safety of FMT in Hepatitis B Reactivation Leads to Acute on Chronic Liver Failure.

Not Applicable
Completed
Conditions
Acute on Chronic Liver Failure
Interventions
Drug: Fecal Microbiota Transplantation (FMT)
First Posted Date
2016-02-23
Last Posted Date
2018-11-23
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
64
Registration Number
NCT02689245
Locations
🇮🇳

Institute of liver and Biliary Sciences, New Delhi, Delhi, India

Efficacy of N-acetylcysteine With or Without Steroids in Drug Induced Liver Injury

Not Applicable
Terminated
Conditions
Drug Induced Liver Injury
Interventions
First Posted Date
2016-02-19
Last Posted Date
2017-12-18
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
4
Registration Number
NCT02686385
Locations
🇮🇳

Institute of liver and Biliary Sciences, New Delhi, Delhi, India

Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver Disease

Withdrawn
Conditions
HBV
NAFLD
HCV
First Posted Date
2016-01-20
Last Posted Date
2019-10-09
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Registration Number
NCT02658786
Locations
🇮🇳

Institute of liver and Biliary Sciences, New Delhi, Delhi, India

Efficacy of Nonselective Beta Blocker vs Placebo in Patients With Acute-on-chronic Liver Failure With Small/ no Esophageal Varices

Not Applicable
Completed
Conditions
Acute on Chronic Liver Failure
Interventions
Drug: Placebo
First Posted Date
2015-10-22
Last Posted Date
2019-06-04
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
136
Registration Number
NCT02583698
Locations
🇮🇳

Institute of liver and Biliary Sciences, New Delhi, Delhi, India

To Compare the Response Rate of Noradrenaline vs. Terlipressin in Hepatorenal Syndrome in Patients With Acute on Chronic Liver Failure

Not Applicable
Completed
Conditions
Acute on Chronic Liver Failure
Interventions
Drug: Nor adrenaline + albumin
First Posted Date
2015-10-12
Last Posted Date
2017-11-17
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
120
Registration Number
NCT02573727
Locations
🇮🇳

Institute of liver and Biliary Sciences, New Delhi, Delhi, India

Safety and Efficacy of Sofosbuvir Based Antiviral Regimen for Treating Hepatitis C in Patients With Moderate to Advanced Chronic Kidney Disease and Patients Receiving Renal Replacement Therapy

Withdrawn
Conditions
CKD With Hepatitis C
First Posted Date
2015-09-30
Last Posted Date
2019-11-05
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Registration Number
NCT02563665
Locations
🇮🇳

Institute of liver and Biliary Sciences, New Delhi, Delhi, India

To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis

Not Applicable
Completed
Conditions
Cirrhosis
Interventions
Other: Placebo
Drug: Metaclopramide
First Posted Date
2015-08-19
Last Posted Date
2017-11-21
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
83
Registration Number
NCT02528760
Locations
🇮🇳

Institute of liver and Biliary Sciences, New Delhi, Delhi, India

The Study of Spectrum of Sleep Disorders in Cirrhotic Patients and the Efficacy of Zolpidem in Cirrhotic Patients With Insomnia

Not Applicable
Completed
Conditions
Cirrhosis
Interventions
Drug: placebo
First Posted Date
2015-06-30
Last Posted Date
2018-05-17
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
52
Registration Number
NCT02484963
Locations
🇮🇳

Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

© Copyright 2025. All Rights Reserved by MedPath